135943-41-8 Usage
Description
1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone is a chemical compound with the molecular formula C16H15NO2. It is a substituted pyridine derivative that contains a methoxyphenyl group and an ethanone functional group. 1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone exhibits potential pharmacological properties and has been studied for its potential use in the treatment of various diseases. Its structure and properties make it a promising candidate for drug development and further research in the field of medicinal chemistry. 1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone's specific activities and potential applications may vary depending on the methods of synthesis and purification, as well as the specific form and concentration in which it is used.
Uses
Used in Pharmaceutical Industry:
1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone is used as a potential therapeutic agent for the treatment of various diseases due to its pharmacological properties. Its unique structure and functional groups allow for further research and development in the field of medicinal chemistry, with the aim of creating new drugs to address unmet medical needs.
Used in Drug Development:
1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone is used as a starting material or intermediate in the synthesis of more complex molecules with potential therapeutic applications. Its versatile structure can be modified and optimized to enhance its pharmacological properties, making it a valuable tool in the development of new drugs.
Used in Medicinal Chemistry Research:
1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone is used as a research compound to study its potential pharmacological activities and mechanisms of action. This can lead to a better understanding of its therapeutic potential and the development of more effective drugs targeting specific diseases.
Note: The specific applications and industries mentioned above are inferred from the general context of the compound's properties and potential uses in the field of medicinal chemistry. The actual applications may vary depending on the results of further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 135943-41-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,9,4 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 135943-41:
(8*1)+(7*3)+(6*5)+(5*9)+(4*4)+(3*3)+(2*4)+(1*1)=138
138 % 10 = 8
So 135943-41-8 is a valid CAS Registry Number.
135943-41-8Relevant articles and documents
A general Suzuki cross-coupling reaction of heteroaromatics catalyzed by nanopalladium on amino-functionalized siliceous mesocellular foam
Bratt, Emma,Verho, Oscar,Johansson, Magnus J,Baeckvall, Jan-Erling
, p. 3946 - 3954 (2014/05/20)
Suzuki-Miyaura cross-coupling reactions of heteroaromatics catalyzed by palladium supported in the cavities of amino-functionalized siliceous mesocellular foam are presented. The nanopalladium catalyst effectively couples not only heteroaryl halides with
PYRIDINE DERIVATIVES
-
Page/Page column 49; 50, (2013/04/13)
The present application provides novel pyridine compounds and pharmaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. These compounds are useful in inhibiting CYP 17 activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with CPY17 activity. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer, such as prostate cancer.
Synthetic routes for a new family of chiral tetradentate ligands containing pyridine rings
Dueggeli, Matias,Goujon-Ginglinger, Catherine,Ducotterd, Sarah Richard,Mauron, David,Bonte, Christophe,Von Zelewsky, Alexander,Stoeckli-Evans, Helen,Neels, Antonia
, p. 1894 - 1899 (2007/10/03)
A series of new tetradentate ligands containing two bipyridine groups or two pyridine moieties carrying amine substituents has been synthesised either from 5′- and 6′-substituted chiral bipyridines, or from chiral pyridine derivatives. These precursors ha
